GILEAD SCIENCES, INC. - Director's Dealing 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-01-31

Reporting Person: YOUNG KEVIN (Chief Operating Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-31	Common Stock	A	7110	—	Acquired	17186	Direct
2018-01-31	Common Stock	F	2259	$83.80	Disposed	14927	Direct
2018-02-01	Common Stock	M	620	—	Acquired	15547	Direct
2018-02-01	Common Stock	F	218	$83.49	Disposed	15329	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-01	Restricted Stock Unit	$	M	620	Disposed		Common Stock (620)	Direct

F1: Issuance of common stock upon vesting of certain performance share awards on January 31, 2018.

F2: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3: The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.